The purpose of this trial is to evaluate the immunogenicity and safety of MenACYW conjugate vaccine compared to those of a licensed product, MENVEO vaccine and also evaluate MenACYW conjugate vaccine when given alone compared to when given with Tdap vaccine and HPV vaccine.